Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? Yes
Write-up: Exsiccosis; suspected Pneumonia bacterial; Dyspnoea; Vigilance decreased; This is a spontaneous report downloaded from the Regulatory Authority-WEB DE-PEI-PEI2021003159. This is a report from a non-contactable physician received form Regulatory Authority. An 82-year-old male patient received bnt162b2 (COMIRNATY), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. Medical history included renal insufficiency, dementia, type 2 diabetes mellitus, all from an unknown date and unknown if ongoing. The patient''s concomitant medications were not reported. On 01Feb2021 after vaccination the patient experienced exsiccosis, suspected pneumonia bacterial, dyspnoea, vigilance decreased. It was reported that there were no dyspnoea symptoms until vaccination. The patient was treated with antibiotic therapy. The events were serious as fatal and life threatening. The patient died on 04Feb2021. It was not reported if an autopsy was performed. Health Authority Relatedness of drug to all events: D. Unclassifiable. The information on the batch/lot number has been requested. ; Reported Cause(s) of Death: Exsiccosis; Pneumonia bacterial; Dyspnoea; Vigilance decreased
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166